Cases 31 - 40 of 220
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv04499
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC, ASTELLAS PHARMA US, INC. and others
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LTD
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2022cv02964
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant:
ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00439
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv01882
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 1:2022cv01882
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00440
Defendant:
Zydus Lifesciences Ltd., Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FRESENIUS KABI USA, LLC v. ZYDUS PHARMACEUTICALS (USA) INC.
as 3:2022cv01702
Plaintiff:
FRESENIUS KABI USA, LLC
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv01592
Plaintiff:
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and CADILA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv01592
Plaintiff:
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and CADILA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
